Beauty Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Beauty Press Releases.

Press releases published on September 9, 2026

Sep. 9, 2026

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

Sep. 9, 2026

PWHL and Scripps Sports Announce National U.S. Television Partnership for 2026-27 Season

Indeterminate GlobeNewswire

Sep. 9, 2026

Academy Sports + Outdoors Reports Second Quarter Fiscal 2026 Results

Indeterminate GlobeNewswire

Sep. 9, 2026

Highwire Launches AcroAnswers, Giving Brands Direct Access to Measure and Improve Their AI Visibility

Indeterminate GlobeNewswire

Sep. 9, 2026

Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

From American Forests to the Architect’s Material Library

Indeterminate GlobeNewswire

Sep. 9, 2026

NervGen to Host Inaugural R&D Day on September 30, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

Indeterminate GlobeNewswire

Sep. 9, 2026

Hammond Power Solutions Included in 2026 TSX30 Ranking

Indeterminate GlobeNewswire

Sep. 9, 2026

Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada

Indeterminate GlobeNewswire

Sep. 9, 2026

Telesat named to the TSX30, ranking among the top performing stocks on the Toronto Stock Exchange

Indeterminate GlobeNewswire

Sep. 9, 2026

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

Sep. 9, 2026

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

Sep. 9, 2026

Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib

Indeterminate GlobeNewswire

Sep. 9, 2026

NEW CHUCK E. CHEESE STATE OF THE BIRTHDAY PARTY REPORT REVEALS WHAT KIDS REALLY WANT FROM THEIR BIRTHDAY PARTIES

Indeterminate GlobeNewswire

Sep. 9, 2026

INLIF LIMITED Announces Adjournment of Extraordinary General Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

Destination XL Group, Inc. Reports Second Quarter Financial Results

Indeterminate GlobeNewswire

Sep. 9, 2026

MapLight Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Indeterminate GlobeNewswire

Sep. 9, 2026

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Indeterminate GlobeNewswire